Invesco
SC0T.DE
IE00B5MJYY16
Invesco STOXX Europe 600 Optimised Health Care UCITS ETF Acc
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Synthetic Replication Note (Swap ETF)

Synthetic (Swap)

The reported holdings, valuation ratios (P/E, etc.), and analyst estimates reflect the fund's underlying collateral/substitute basket, not the actual composition of the tracked index.

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
20.76
Weighted Fwd P/E
17.18
Avg P/FCF
21.12
Avg FCF Yield
4.33%
Avg EV / EBITDA
15.53
Avg EV / Revenue
11.44
Avg Price-to-Book (P/B)
83.07
Avg Price-to-Sales (P/S)
12.42
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
-17.26%
Avg Debt-to-Equity (D/E)
68.10%
<50% (29.95%) 50-150% (69.01%) >150% (0.78%) Unreported (0.26%)

Profitability Analysis

43 Holdings Count
Profitable 99.48%
Profitable 99.48%
42 Holdings Count (97.67%)
Unprofitable 0.52%
1 Holdings Count (2.33%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

High Concentration (Top-Heavy)
Top 5
45.9%
Top 10
67.6%
Top 25
92.0%
50% Threshold
Top 6
The top 10 holdings account for 67.6% of the total ETF. Performance is heavily driven by a few heavyweights. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

11 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (8.3%+)
High (21.5%+)
Top (29.8%+)

Country Breakdown

Max: 33.15%
CH CH CH
33.15%
GB GB GB
19.93%
DK DK DK
14.50%
FR FR FR
12.42%
DE DE DE
8.88%
NL NL NL
5.80%
BE BE BE
2.41%
SE SE SE
1.12%
FI FI FI
0.69%
LU LU LU
0.64%
IT IT IT
0.45%

Sector Distribution

2 Sector
Healthcare
98.33%
Basic Materials
1.67%

Industry Distribution

8 Industries
Drug Manufacturers - General
57.64%
Drug Manufacturers - Specialty & Generic
10.91%
Medical Instruments & Supplies
9.45%
Biotechnology
8.59%
Diagnostics & Research
4.96%
Medical Devices
4.75%
Medical Care Facilities
2.04%
Specialty Chemicals
1.67%

Market Cap Distribution

43 Holdings Count
Mega Cap (> 200B)
(3) 28.83%
Large Cap (10B - 200B)
(30) 67.73%
Mid Cap (2B - 10B)
(10) 3.43%
ende